Viewing Opinion | StockChase

Teva Pharmaceutical (TEVA-N) opinion on 2017-08-11

Last Price Recorded: 18.6100 on 2017-12-15

ON STOCKCHASE SINCE Dec 2000

biotechnology/pharmaceutical
biotechnology/pharmaceutical
DON'T BUY

Darren Sissons
Teva Pharmaceutical was $17.300 at time of opinion
Owned : No

A very complicated business. It is contractually driven. They build the company based on accumulating assets from institutional investors. The stock has been a fabulous performer. He thinks there is more upside.

UNKNOWN

All opinions for TEVA-N (238)

45 BUY
4 BUY on WEAKNESS
45 COMMENT
41 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

All opinions for TEVA-N (238)

45 BUY
4 BUY on WEAKNESS
45 COMMENT
41 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

Last 60 Days Opinions

DON'T BUY
1 week ago
COMMENT
2 weeks ago
COMMENT
3 weeks ago
DON'T BUY
3 weeks ago
PAST TOP PICK
3 weeks ago
DON'T BUY
4 weeks ago
COMMENT
1 month ago
COMMENT
1 month ago
COMMENT
1 month ago
COMMENT
1 month ago

No Comments.


You must be logged in to comment.

Successfully Saved Company